Stock Markets May 19, 2026 08:53 AM

Amesite Shares Jump After Firm Wins Largest Enterprise Customer for NurseMagic Platform

2,700-patient deployment, EMR and EVV integrations, and fiscal efficiency highlighted as company scales enterprise footprint

By Nina Shah AMST

Amesite Inc. (NASDAQ: AMST) saw a sharp premarket rally after announcing a 2,700-patient deployment of its NurseMagic AI documentation platform, marking the company’s largest enterprise customer to date. The platform will integrate with electronic medical record (EMR) and electronic visit verification (EVV) systems and is designed to reduce caregiver administrative time. Company executives also reported operating-spend reductions and growing sales engagement metrics.

Amesite Shares Jump After Firm Wins Largest Enterprise Customer for NurseMagic Platform
AMST

Key Points

  • Amesite secured its largest enterprise client to date, covering roughly 2,700 patients, driving a 190% premarket jump in AMST shares.
  • The NurseMagic deployment will integrate with EMR and EVV systems, support multiple roles and layered permissions, and aims to reduce administrative burdens that can reach up to 16 hours per caregiver per week - impacting health care technology and home health operations.
  • Executives reported about an 18% reduction in operating spend over the past six quarters while serving a growing paying customer base; the company also cited roughly 4,200 daily web visits and ongoing discussions with organizations representing several thousand potential additional patients.

Amesite Inc. (NASDAQ: AMST) shares surged 190% in premarket trading following disclosure that the company has secured its largest enterprise customer so far, an account with an approximate census of 2,700 patients.

The customer will roll out NurseMagic, Amesite’s AI-first documentation solution, across its workforce. According to the company, the platform will be integrated with the customer’s electronic medical record (EMR) and electronic visit verification (EVV) systems and is expected to address administrative tasks that the company says can consume as much as 16 hours per caregiver each week.

Company statements emphasize the scale increase this engagement represents for NurseMagic’s enterprise footprint. Amesite said the deployment will accommodate multiple user roles with layered permissions, support EMR and EVV integration, and enable custom documentation workflows across thousands of patients.

Dr. Ann Marie Sastry, Founder and CEO of Amesite, described the deployment as validation of the platform architecture. She said the technology supports multiple roles, layered permissions, EMR and EVV integration, and custom documentation across thousands of patients - and that these capabilities are delivered without what the company characterized as the heavy consulting, technology fees, and custom development that often accompany legacy vendors. Dr. Sastry added that NurseMagic’s AI-first, automated and configurable design allows Amesite to onboard new customers rapidly, avoiding weeks or months of onboarding.

From a financial operations perspective, Sarah Berman, Principal Finance and Accounting Officer, stated that the deployment was executed while maintaining fiscal discipline. Berman noted that Amesite achieved approximately an 18% reduction in operating spend over the last six quarters while continuing to support a growing base of paying customers.

On sales and marketing, Madison Bush, Director of Corporate Operations, said the company’s efforts are generating about 4,200 web visits per day. Amesite is engaged in discussions with additional organizations that together would represent several thousand more patients in aggregate census, and the company reported that more than 70% of those prospective organizations have self-scheduled demonstrations on the website.


Context and implications

The announced 2,700-census deployment is presented by the company as a material increase in the scale of its enterprise footprint for NurseMagic. Company executives highlighted both platform capabilities and recent operational efficiencies as key elements of the development. The firm also signaled an active sales pipeline with additional discussions underway.

Risks

  • The company is in discussions with additional organizations representing several thousand patients in aggregate, but those discussions are not guaranteed to convert to signed contracts - a sales-conversion risk impacting future revenue growth.
  • Maintaining the reported approximately 18% reduction in operating spend while continuing to scale deployments and support a growing customer base may present operational and cost-management challenges.
  • Large-scale integrations with EMR and EVV systems, and the need to support multiple roles and custom documentation across thousands of patients, introduce execution complexity that could affect deployment timelines or resource requirements.

More from Stock Markets

S&P Global Upholds Fast-Entry Rules Ahead of SpaceX Public Debut Jun 4, 2026 Insperity Shares Climb After CEO Buys 233,000 Shares Jun 4, 2026 SpaceX Signals Firmness on $135 IPO Price as Roadshow Begins Jun 4, 2026 CME Chief Warns CFTC Approval of Perpetual Crypto Futures Could Create Systemic Risk Jun 4, 2026 AmperCap Raises $125 Million in NASDAQ Listing as It Targets U.S.-Mexico Middle-Market Deals Jun 4, 2026